# Study to Evaluate the Efficacy of Botulinum Toxin Serotype A Injections for Cervicobrachial Myofascial Syndrome

> **NCT00241215** · PHASE4 · COMPLETED · sponsor: **University of California, Los Angeles** · enrollment: 132 (actual)

## Conditions studied

- Cervicobrachial Neuralgia
- Myofascial Pain Syndromes

## Interventions

- **DRUG:** Botulinum toxin serotype A

## Key facts

- **NCT ID:** NCT00241215
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2005-11
- **Final completion:** —
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2016-06-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00241215

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00241215, "Study to Evaluate the Efficacy of Botulinum Toxin Serotype A Injections for Cervicobrachial Myofascial Syndrome". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00241215. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*